Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹115 Cr₹85 Cr₹71 Cr₹42 Cr₹44 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹115 Cr based on Mar2024 Standalone results.
Year Revenue
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr
Mar2020₹44 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr
-2.65
Mar2020 ₹44 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹208.6 Cr 2.5% 18.3% 2.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 3.6% 2.5% 6.2% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.9% 1.5% 48.1% Stock Analytics
CIPLA ₹120,428.0 Cr -0.1% -2.4% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.9% 15.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -0.7% -6.4% -5.2% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

2.5%

18.3%

2.5%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses